Brazilian startup Carecode has launched with a US$4.3 million pre-seed round. The company is developing AI agents to automate the administrative work surrounding medical appointments – tasks typically handled by healthcare call centers. These automated capabilities include appointment scheduling, confirmations, rescheduling and managing cancellations. The AI can also proactively fill cancelled time slots and escalate complex cases to human staff when needed.
The system is designed for the Brazilian market and integrates with WhatsApp, supporting both text and voice messages to accommodate older and low-income users who prefer audio communication. According to early pilot results, Carecode’s AI can perform most of a call center’s workload at a significantly lower cost. The startup currently targets Brazil’s healthcare sector, where administrative and call center costs account for an estimated 50% of provider revenue, or roughly US$100 billion annually.
Wing, the Alphabet-owned company specializing in drone delivery of medicine, groceries and fast-food, has announced a major expansion of its partnership with Walmart to expand its grocery delivery…
As TechCrunch recently reported, YouTube has won the rights to stream the Oscars, Hollywood’s glitziest awards ceremony, exclusively on its platform beginning in 2029. For these rights, the online…
Xposure Technology Inc. (“Xposure Music”), a technology-driven financing and investment platform, leverages data analytics and artificial intelligence to identify and acquire music catalogs that it…
Lego’s new Smart Play system has added interactive Lego blocks to the well-known analog franchise. The new system makes use of smart bricks, smart tag tiles and smart minifigures which interact with…
The development of robotaxis from companies such as Waymo LLC and Zoox, Inc. has sparked broader conversations about how autonomous vehicles will integrate into everyday life. For this integration to…
The Business Development Bank of Canada (“BDC”) has indicated it may ease restrictions that have historically limited venture capital funds it backs from investing in defence-related technologies…
